ES540907A0 - Un metodo de producir una composicion farmaceutica estabili-zada - Google Patents
Un metodo de producir una composicion farmaceutica estabili-zadaInfo
- Publication number
- ES540907A0 ES540907A0 ES540907A ES540907A ES540907A0 ES 540907 A0 ES540907 A0 ES 540907A0 ES 540907 A ES540907 A ES 540907A ES 540907 A ES540907 A ES 540907A ES 540907 A0 ES540907 A0 ES 540907A0
- Authority
- ES
- Spain
- Prior art keywords
- zada
- stabili
- producing
- pharmaceutical composition
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59043265A JPS60185727A (ja) | 1984-03-05 | 1984-03-05 | ４−カルバモイルイミダゾリウム−５−オレ−ト製剤の安定化法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8700936A1 ES8700936A1 (es) | 1986-11-16 |
| ES540907A0 true ES540907A0 (es) | 1986-11-16 |
Family
ID=12659008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES540907A Expired ES8700936A1 (es) | 1984-03-05 | 1985-03-04 | Un metodo de producir una composicion farmaceutica estabili-zada |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0159777A1 (es) |
| JP (1) | JPS60185727A (es) |
| KR (1) | KR850006131A (es) |
| CA (1) | CA1235065A (es) |
| ES (1) | ES8700936A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950010150B1 (ko) * | 1986-01-14 | 1995-09-11 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 함유 주사제의 안정화 방법 |
| JP5266010B2 (ja) | 2007-09-14 | 2013-08-21 | 富士フイルム株式会社 | ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物 |
| JP5458777B2 (ja) | 2009-09-28 | 2014-04-02 | 株式会社ジェイテクト | ダブルカルダンジョイントのカップリングヨーク |
| JP2013082706A (ja) * | 2011-09-28 | 2013-05-09 | Fujifilm Corp | ５−ヒドロキシ−１ｈ−イミダゾール−４−カルボキサミド水和物の結晶 |
| RU2672560C1 (ru) | 2011-09-28 | 2018-11-16 | Фуджифилм Корпорэйшн | Кристалл гидрата 5-гидрокси-1Н-имидазол-4-карбоксамида и фармацевтическая композиция на его основе |
| JP5726830B2 (ja) * | 2011-09-28 | 2015-06-03 | 富士フイルム株式会社 | ５−ヒドロキシ−１ｈ−イミダゾール−４−カルボキサミド・３／４水和物の結晶及びその製造方法 |
| JP6001684B2 (ja) * | 2013-01-15 | 2016-10-05 | 富士フイルム株式会社 | ５−ヒドロキシ−１ｈ−イミダゾール−４−カルボキサミドの硫酸塩 |
| EP2946780B1 (en) | 2013-01-15 | 2017-03-01 | FUJIFILM Corporation | Tablet containing 5-hydroxy-1h-imidazole-4-carboxamide |
| WO2014112531A1 (ja) * | 2013-01-15 | 2014-07-24 | 富士フイルム株式会社 | ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミドもしくはその塩またはその水和物を含む固形製剤の包装体 |
| WO2019082898A1 (ja) | 2017-10-27 | 2019-05-02 | 富士フイルム株式会社 | ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド・３／４水和物の製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4181731A (en) * | 1976-09-07 | 1980-01-01 | Sumitomo Chemical Company, Limited | Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole |
| EP0051962B1 (en) * | 1980-11-05 | 1988-08-24 | Sumitomo Chemical Company, Limited | Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate |
-
1984
- 1984-03-05 JP JP59043265A patent/JPS60185727A/ja active Granted
-
1985
- 1985-02-21 EP EP85301164A patent/EP0159777A1/en not_active Ceased
- 1985-02-27 CA CA000475351A patent/CA1235065A/en not_active Expired
- 1985-03-04 KR KR1019850001346A patent/KR850006131A/ko not_active Application Discontinuation
- 1985-03-04 ES ES540907A patent/ES8700936A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES8700936A1 (es) | 1986-11-16 |
| JPH0137376B2 (es) | 1989-08-07 |
| CA1235065A (en) | 1988-04-12 |
| KR850006131A (ko) | 1985-10-02 |
| EP0159777A1 (en) | 1985-10-30 |
| JPS60185727A (ja) | 1985-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES542028A0 (es) | Un metodo de producir una composicion de interleuquina-2 | |
| ES545892A0 (es) | Un metodo de producir un cigarrillo | |
| ES547578A0 (es) | Un metodo de produccion de una solucion inyectable de un antraciclina glicosido | |
| KR860003007A (ko) | 캡슐 밀봉방법 | |
| ES542686A0 (es) | Una composicion piro-retardante | |
| ES541394A0 (es) | Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada | |
| ES548407A0 (es) | Un metodo de fabricar una aleacion semiconductora | |
| ES544672A0 (es) | Un procedimiento para preparar una composicion de esmalte deunas | |
| ES539006A0 (es) | Un metodo de fabricacion de una material de friccion | |
| ES519771A0 (es) | Un metodo de producir una preparacion farmaceutica que contiene un derivado de sulfonil urea. | |
| FI92053B (fi) | Analogiamenetelmä uuden lääkkeen valmistamiseksi | |
| ES540907A0 (es) | Un metodo de producir una composicion farmaceutica estabili-zada | |
| ES547776A0 (es) | Una composicion de toluenodiamina | |
| ES525656A0 (es) | Un metodo de preparar profarmacos de pilocarpina | |
| ES530184A0 (es) | Metodo de producir una preparacion yodofora farmaceutica | |
| BR8300075A (pt) | Eletrodo funcional e metodo de produzir um eletrodo funcional | |
| ES541574A0 (es) | Un metodo para producir una hidrioma de ser humano.ser humano productor de anticuerpos antitetanicos. | |
| ES549958A0 (es) | Un metodo de fabricar una unidad electrolitica | |
| ES550537A0 (es) | Un metodo para la produccion de una composicion moldeada | |
| ES534261A0 (es) | Un metodo de produccion de una composicion de aclarrubicina o hidrocloruro de aclarrubicina | |
| ES539737A0 (es) | Un metodo de producir una composicion de gamma-interferon dehumano | |
| ES498756A0 (es) | Un metodo de produccion de una composicion farmaceutica paraadministracion rectal | |
| ES539542A0 (es) | Un metodo de preparar terpinen-4-ol | |
| ES537638A0 (es) | Un metodo de producir una composicion moldeable | |
| IT1209936B (it) | L-serina metodo per la produzione di |